A Comparison of Lifestyle,Genetic,Bioclinical and Biochemical Variables of Offspring with and without Family Histories of Premature Coronary Heart Disease: The Experience of the European Atherosclerosis Research Studies

Abstract

Background

Lifestyle, genetic, bioclinical and biochemical factors of European university students aged 18–26 years, with and without documented paternal histories of premature coronary heart disease, have been compared in the European Atherosclerosis Research Studies (EARS) I and II.

Objective

To highlight consistencies and inconsistencies between findings in the two studies.

Methods

All measurements were made according to strict protocols, by trained technicians using validated methods. The results for men in EARS I are compared with those from EARS II which was confined to men.

Results

In both studies we found no differences between cases and controls in lifestyle factors and bioclinical factors except that controls were taller, We found inconsistent differences between obesity indices and antecedents of arterial hypertension. In both studies we found consistent differences between cases and controls in levels of total cholesterol and apolipoprotein B, both levels being higher in cases. The lack of any difference between levels of high-density lipoprotein cholesterol and apolipoprotein A1 was also found consistently. Inconsistent differences were found for levels of triglycerides and apolipoprotein E. For most of the candidate genes that were studied, no differences between cases and controls were found, but different polymorphisms were associated with levels of lipids, apoproteins and fibrinogen independently of case–control status. Some of these associations were potentiated by lifestyle factors. The interaction between genetic and environmental factors is further illustrated with results from the association of apolipoprotein E polymorphism with the level of apolipoprotein B and a variety of other determinants of apolipoprotein B level.

Conclusions

In the EARS studies a documented family history of premature coronary heart disease was mainly expressed in terms of biochemical factors that are determined both by nature and by nurture.

Keywords

risk factors genetic family history coronary heart disease

Get full access to this article

View all access options for this article.

References

The EARS group. European Atherosclerosis Research Study. Design and objectives. Int J Epidemiol 1994; 23: 440–463.

The EARS group. The distribution of fasting plasma lipid concentrations in the offspring of men with premature coronary heart disease in Europe. The EARS study. Int J Epidemiol 1994; 23: 472–481.

Turner

Talmud

Visvikis

Ehnholm

Tiret

. DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis 1995; 116: 221–234.

Talmud

Humphries

on behalf of the EARS group. Polymorphism in the promotor region of the apolipoprotein A1 gene associated with differences in apolipoprotein A1 levels: the European Atherosclerosis Research Study. Genet Epidemiol 1994; 11: 265–280.

Ehnholm

Tenkanen

De Knijff

Havekes

Rosseneu

Menzel

on behalf of the EARS group. Genetic polymorphism of the apolipoprotein AIV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. Atherosclerosis 1994; 107: 229–238.

Tiret

De Knijff

Menzel

Ehnholm

Nicaud

Havekes

for the EARS group. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study, Arterioscler Thromb 1994; 14: 1617–1624.

Humphries

Nicaud

Margalef

Tiret

Talmud

. Lipoprotein lipase gene variation is associated with paternal history of premature coronary artery disease and fasting and post-prandial plasma triglycerides: European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 1998; 18: 526–534.

Gerdes

Fisher

Nicaud

Boer

Humphries

Talmud

on behalf of the EARS group. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglycerides and lower high-density lipoprotein cholesterol concentrations. Circulation 1997; 96: 733–740.

Gudnason

Stansbie

Scott

Bowzon

Nicaud

Humphries

on behalf of the EARS group. The C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR); its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 1998; 136: 347–354.

10.

Humphries

Talmud

Bara

Wilhelmsen

Tiret

, on behalf of the EARS group. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G_-455-Aβ-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender–genotype–environment interaction. Arterioscler Thromb Vasc Biol 1995; 15: 96–104.

11.

Klausen

Beisiegel

Menzel

Rosseneu

Nicaud

Faergeman

on behalf of the EARS group. Apo (a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS study. Arterioscler Thromb Vasc Biol 1995; 15: 1001–1008.

12.

Masana

Farinaro

De Henauw

Nicaud

. Blood pressure in young adults with and without a paternal history of premature coronary heart disease in Europe: the EARS study. J Hum Hypertens 1996; 10: 207–213.

13.

Kee

Nicaud

Tiret

Evans

O'Reilly

De Backer

for the EARS group. Short stature and heart disease: nature of nurture? Int J Epidemiol 1997;26: 748–755.

14.

Bara

Nicaud

Tiret

Cambien

Samaina

on behalf of the EARS group. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VII and PAI-I in European offspring. The EARS study. Thromb Haemost 1994; 71: 434–440.

15.

Rosseneu

Fruchart

Bara

Nicaud

Vinaimont

Cambien

on behalf of the EARS group. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation 1994; 89: 1967–1973.

16.

Sing

Davignon

. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37: 268–289.

17.

Boerwinkle

Utermann

. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism. Am J Hum Genet 1988; 42: 104–112.

18.

Smit

De Knijff

Rosseneu

Bury

Klasen

Frents

Apolipoprotein E polymorphism in The Netherlands and its effects on plasma lipid and apolipoprotein levels. Hum Genet 1988; 80: 287–292.

19.

Braeckman

De Bacquer

Rosseneu

De Backer

. Apolipoprotein E polymorphism in middle-aged Belgian men: phenotype distribution and relation to serum lipids and lipoprotein. Atherosclerosis 1996; 120: 67–73.

20.

Lehtimähi

Moilanen

Viikari

Akerblom

Ehnholm

Rönnemaa

Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487–495.

21.

Hallman

Boerwinkle

Saha

Sandholzer

Menzel

Csazar

The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338–349.

22.

Hanis

Hewett-Emmett

Douglas

Bertin

Schull

. Effects of the apolipoprotein E polymorphisms on levels of lipids, lipoproteins and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler Thromb 1991; 11: 362–370.

23.

Talmud

Angelico

DelBen

Savill

Humphries

. Apolipoprotein E polymorphism and plasma lipid lipoprotein and apolipoprotein levels in Italian children. Genet Epidemiol 1991; 8: 389–398.

24.

Boer

Ehnholm

Menzel

Havekes

Rosseneu

O'Reilly

for the EARS group. Interactions between lifestyle-related factors and the apo E polymorphism on plasma lipids and apolipoproteins. The EARS study. Arterioscler Thromb Vasc Biol 1997; 17: 1675–1681.